A
Arivale
Arivale - Your Scientific Path to Wellness
About Arivale
Arivale, founded in 2015, was a pioneering startup in the wellness and health industry. The company aimed to revolutionize personal health management through a data-driven, personalized coaching program. Arivale's approach involved collecting extensive data from its participants, including genomic information, blood analytes (substances measured in blood tests), gut microbiome (the bacteria in the digestive system), and digital self-measurements. This data was then analyzed using systems and behavioral science to provide tailored health recommendations aimed at improving wellness and preventing disease.
Arivale primarily served health-conscious consumers who were interested in a scientific approach to wellness. These clients were typically individuals looking to proactively manage their health through personalized insights and recommendations. The market Arivale operated in was the burgeoning field of quantitative wellness, which combines scientific data collection with health coaching to offer a new paradigm in preventive health care.
The business model of Arivale was direct-to-consumer, meaning they sold their services directly to individuals rather than through intermediaries like insurance companies or healthcare providers. They made money by charging participants for the comprehensive health assessments and personalized coaching services. However, despite the high levels of customer satisfaction and significant improvements in health markers reported by participants, the cost of providing these services exceeded what customers were willing or able to pay. This financial imbalance led to the termination of the consumer program.
Arivale's work has been recognized for its scientific merit, with a study involving 2,500 participants accepted for publication in the journal Scientific Reports. The company believes that as the costs of genetic, blood, and microbiome assays decrease, their model will become viable again in the future.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2014
- Headquarters
- Seattle, United States
- Employees
- 41
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Genome Engineering, Direct-to-Consumer, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jun 2017 | $14M | $54M | Undisclosed | — |
| SERIES BOther financing | Jul 2015 | $36M | $144M | Polaris Partners · Maveron · ARCH Venture Partners | — |
Growth signals
Latest recorded traffic for Arivale is 560 monthly website visits, down 73.3% over the last three months. Arivale's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arivale on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arivale’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










